Long-term experience with tepotinib in Japanese patients with MET exon 14 skipping NSCLC from the Phase II VISION study
来自 II 期 VISION 研究的日本 MET 外显子 14 跳跃型非小细胞肺癌患者使用 tepotinib 的长期经验
期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.16107
Morise, Masahiro; Kato, Terufumi; Matsumoto, Shingo; Inoue, Takako; Sakamoto, Tomohiro; Tokito, Takaaki; Atagi, Shinji; Kozuki, Toshiyuki; Takeoka, Hiroaki; Chikamori, Kenichi; Shinagawa, Naofumi; Tanaka, Hiroshi; Horii, Eisuke; Adrian, Svenja; Bruns, Rolf; Johne, Andreas; Paik, Paul K; Sakai, Hiroshi